share_log

博安生物:自願性公告度拉糖肽注射液(BA5101)在中國完成III期臨床試驗及計劃遞交上市申請

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTPHASE 3 CLINICAL TRIAL COMPLETED IN CHINA FORDULAGLUTIDE INJECTION (BA5101) AND BLA TO BE FILED

HKEX ·  Mar 7 23:28
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more